Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Track record
Movers
Home
›
Targets
› TNFα
TNFα
(2 companies · 2 programs)
Companies with an active program directed at TNFα.
Oculis Holding AG
OCS
Licaminlimab
— Dry Eye Disease
Phase 2
Zenas BioPharma, Inc.
ZBIO
ZB002